Overview

A Study to Learn About a Vaccine Against E Coli in Healthy Adults

Status:
RECRUITING
Trial end date:
2028-05-25
Target enrollment:
Participant gender:
Summary
This study evaluates an investigational vaccine designed to protect against Escherichia coli (E coli). The primary objective is to assess the safety and tolerability of E coli vaccines administered intramuscularly to healthy adults.
Phase:
PHASE1
Details
Lead Sponsor:
Pfizer